a Institute of Cardiovascular Sciences , University of Birmingham , Birmingham , UK.
b Liverpool Centre for Cardiovascular Science , University of Liverpool and Liverpool Heart & Chest Hospital , Liverpool , UK.
Ann Med. 2019 May-Jun;51(3-4):193-223. doi: 10.1080/07853890.2019.1609076. Epub 2019 Jun 17.
Microparticles are a distinctive group of small vesicles, without nucleus, which are involved as significant modulators in several physiological and pathophysiological mechanisms. Plasma microparticles from various cellular lines have been subject of research. Data suggest that they are key players in development and manifestation of cardiovascular diseases and their presence, in high levels, is associated with chronic inflammation, endothelial damage and thrombosis. The strong correlation of microparticle levels with several outcomes in cardiovascular diseases has led to their utilization as biomarkers. Despite the limited clinical application at present, their significance emerges, mainly because their detection and enumeration methods are improving. This review article summarizes the evidence derived from research, related with the genesis and the function of microparticles in the presence of various cardiovascular risk factors and conditions. The current data provide a substrate for several theories of how microparticles influence various cellular mechanisms by transferring biological information.
微粒是一类具有独特特征的小囊泡,没有细胞核,它们作为重要的调节剂参与了多种生理和病理生理机制。来自不同细胞系的血浆微粒一直是研究的对象。有数据表明,它们是心血管疾病发展和表现的关键因素,其高水平存在与慢性炎症、内皮损伤和血栓形成有关。微粒水平与心血管疾病的多种结局的强相关性导致了它们作为生物标志物的应用。尽管目前的临床应用有限,但它们的意义正在显现,主要是因为它们的检测和计数方法在不断改进。本文综述了与各种心血管危险因素和疾病存在时微粒的发生和功能相关的研究证据。目前的数据为几种理论提供了依据,这些理论解释了微粒如何通过传递生物信息来影响各种细胞机制。